Highlights
A collection of news and information related to Food and Drug Administration published by this site and its partners.
Displaying items 1-12 of 1627
» View wsbtradio.com items only
1
2
3
4
5
6
7
8
9
10
11-136
•
Next >
-
Links To Sites You Hear On Newsradio 960-WSBT
May 20, 2013: Indiana No Call List April 12, 2013: Peregrine Falcon Cam April 12, 2013: IOSHA investigation April 11, 2013: Indiana unclaimed property April 10, 2013: Frozen food recall April 3, 2013: Indiana long term insurance policy...Tags: Peanut Butter, Politics, Graco Incorporated, Tylenol (drug), Criminal Minds: Suspect Behavior (tv program)
-
FDA panel: Merck's insomnia drug effective, safe at low doses
ReutersWASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. The panel, which advises the U.S. Food and Drug...Tags: Merck & Company Incorporated, Insomnia
-
FDA PANEL: MERCK SHOULD NOT HAVE TO PERFORM
ReutersFDA PANEL: MERCK SHOULD NOT HAVE TO PERFORM ADDITIONAL CLINICAL STUDIES OF THE 10 MG DOSE OF INSOMNIA DRUG SUVOREXANT -
FDA PANEL: MERCK'S INSOMNIA DRUG SUVOREXANT IS
ReutersFDA PANEL: MERCK'S INSOMNIA DRUG SUVOREXANT IS SAFE TO BE STARTED AT 15 MG IN THE ELDERLY AND 20 MG IN NON-ELDERLY PATIENTS -
FDA PANEL: MERCK'S EXPERIMENTAL INSOMNIA DRUG
ReutersFDA PANEL: MERCK'S EXPERIMENTAL INSOMNIA DRUG SUVOREXANT IS NOT SAFE AT HIGHER DOSES IN PATIENTS WHO DO NOT RESPOND TO LOWER DOSES -
FDA panel favors Merck sleeping aid despite safety concerns over drowsiness, driving issues
AP Health WriterWASHINGTON (AP) — A federal panel of medical experts said that an experimental insomnia drug from Merck & Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. A...Tags: Politics, Elections, Merck & Company Incorporated, Insomnia, Ambien (drug)
-
READER SUBMITTED: Connecticut's First Robotic-Assisted Single Site Hysterectomy
HartfordA surgical team at Hartford Hospital performed the state's and New England's first da Vinci - or robotic-assisted single site hysterectomy on May 2. The patient's uterus was removed through one tiny incision in the belly button, making the procedure...Tags: Hartford Hospital, Women's Health, Hospitals and Clinics, Hysterectomy
-
In debate over 'biosimilars,' patient safety must come first
In 1988, I became extremely ill. I had many tests, saw many doctors and was given various medicines. Some caused allergic reactions. Through it all, I remained sick — and actually became worse. Eventually, I was diagnosed with autoimmune hepatitis,...Tags: Health and Medical Professionals, Rheumatoid Arthritis, Allergies, Hepatitis, Maryland General Assembly
-
Howard County pets: What's the hype about raw diets?
Q: I’ve heard a lot about raw dog food, but it seems pricey. Is it safe? Are the health benefits substantial? A: Raw diets for dogs (including raw meat) have become increasingly popular. Some pet owners -- even some veterinarians -- swear by them,...
Tags: Arable Farming, Animal Science, Food Industry, Allergies, Diseases and Illnesses
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Vaccines, Merck & Company Incorporated, AstraZeneca Plc, HIV, Chemotherapy
-
Immune system cancer drugs tipped to be a $35 billion market
ReutersLONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...Tags: Vaccines, Merck & Company Incorporated, AstraZeneca Plc, HIV, Chemotherapy
-
The Doctor's Corner: An early start on treating menopause
This is the first of a two-part series updating women of all ages on the use of hormones. It is a pleasure to be back putting pencil to paper with good news for women going through "the change." A Global Consensus Statement, hot off the press in the...Tags: Osteoporosis, Healthcare Provider, Fatigue, Yale University, Gynecology
Oct 19, 2010
|Story| WSBT Radio
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| AP Broadcast
May 22, 2013
|Story| Hartford Courant
May 22, 2013
|Story| Baltimore Sun
May 22, 2013
|Story| Baltimore Sun
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 21, 2013
|Story| Coastline Pilot
Original site for Food and Drug Administration topic gallery.